This inventor holds 1 USPTO granted patent. Top assignee: Profos Ag. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Andrew John Morgan
Introduction
Andrew John Morgan is a notable inventor based in Haywards Heath, GB. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutics. His work focuses on utilizing bacteriophages to combat pathogenic bacteria, which is crucial in addressing antibiotic resistance.
Latest Patents
Morgan holds a patent for a nucleic acid comprising a nucleotide sequence encoding a lysin. This nucleotide sequence includes the sequence shown in SEQ ID No. 1 or a variant, homologue, or derivative thereof. The patent describes a novel lysin obtainable from a bacteriophage capable of colonizing pathogenic bacteria, with potential applications as a medicament for treating related disorders.
Career Highlights
Morgan is currently associated with Profos Ag, a company dedicated to advancing biotechnological solutions. His innovative work has positioned him as a key figure in the development of new therapeutic strategies against bacterial infections.
Collaborations
He has collaborated with esteemed colleagues such as Markus Zimmer and Martin Loessner, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Andrew John Morgan's contributions to biotechnology through his patent and collaborative efforts highlight the importance of innovation in addressing global health challenges. His work exemplifies the potential of bacteriophage therapy in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile